Celldex Therapeutics shares owned by Principal Financial Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Principal Financial Group
from 13F filings
Historical chart of Principal Financial Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Principal Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $552k | 13k | 41.97 |
| 2023-12-31 | $474k | 12k | 39.66 |
| 2023-09-30 | $354k | 13k | 27.52 |
| 2023-06-30 | $385k | 11k | 33.93 |
| 2023-03-31 | $434k | 12k | 35.98 |
| 2022-12-31 | $475k | 11k | 44.57 |
| 2022-09-30 | $297k | 11k | 28.20 |
| 2022-06-30 | $232k | 8.6k | 26.89 |
| 2022-03-31 | $1.4M | 43k | 34.06 |
| 2021-12-31 | $2.2M | 58k | 38.64 |
| 2021-09-30 | $5.0M | 93k | 53.99 |
| 2021-06-30 | $2.8M | 84k | 33.43 |